According to three new studies presented at the American Association for Cancer Research conference in Philadelphia, one of the brand new cancer immunotherapy drugs, Keytruda, manufactured by Merck & Company is working well for patients with mesothelioma, which is a rare but difficult to treat cancer caused by asbestos exposure that mainly affects the lungs.
In a study of 25 patients with mesothelioma who had not been helped by chemotherapy, for whom there are normally no further treatment options, they were treated with Keytruda for an average of 5 ½ months. Of those patients, 76 percent were helped with 28 percent having tumors shrink and in 48 percent the tumors stopped growing. Ten patients were still taking the drug and two had not yet been assessed.
Normally, of those who do not respond to chemotherapy the first time, only 10 percent usually respond to another type and therefore the results are seen to be very encouraging.
If you have been diagnosed with any an asbestos related disease, you may be entitled to monetary compensation. To find out how we can help you recover for your asbestos related claim, contact the Law Office of Brayton Purcell, LLP at (800) 598-0314 immediately, or contact us online for a free consultation.
